ReviewInternational journal of nanomedicine2026

Nanomedicine in 2026: Illustrative Quantitative Analyses of EPR Heterogeneity, Clinical Trial Attrition, and Emerging Horizons for Active Nanotherapeutics.

Sayed Mortaza FayezPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.